Cancer Research Institute Names Newest Class of Lloyd J. Old STARs, Today's Visionaries in Cancer Immunotherapy Research
UCSF's Kole Roybal, PhD and Matt Spitzer, PhD were named among six U.S. scientists to be awarded $1.25 million each over 5 years to conduct high-risk, high-reward cancer immunology research with the potential to transform cancer treatment.
A world-class team of researchers, co-led by UCSF’s Allan Balmain, and including Kim Rhoads and Luke Gilbert, has been selected to receive a $25M Cancer Grand Challenges award to investigate the very early stages of cancer development.
In a groundbreaking finding, a new study led by UC San Francisco found that routine screening for and removal of precancerous anal lesions can significantly reduce the risk of anal cancer, similar to the way cervical cancer is prevented in women.
The global incidence of head and neck cancers have increased considerably over the past decade. In the latest CureTalks podcast, Dr. Patrick Ha and head and neck cancer warrior Sean Breininger discuss the current standard of care, and differences in prognosis & treatment of HPV positive and HPV negative patients.
Announcing the Cancer Center See Us Portrait Project, a series of portraits and quotes by Black, Indigenous, People of Color (BIPOC) faculty and staff who are dedicated leaders in diversity, equity, and inclusion, and exhibit UCSF's PRIDE values.
Research scientists and statisticians from UC San Francisco have developed improved biomarker classifications as part of their research results in the I-SPY 2 trial for high-risk breast cancer patients. The new cancer response subtypes reflect responsiveness to drug treatments and are intended to help clinicians be more precise in how they target therapies.
The latest advances in cancer care and research will be showcased at the annual American Society of Clinical Oncology (ASCO) Annual Meeting, the world’s largest clinical cancer meeting.